Company Filing History:
Years Active: 2020-2023
Title: Innovations of Luis Soenksen in Microphysiological Systems
Introduction
Luis Soenksen is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of microphysiological systems. With a total of 2 patents, his work focuses on enhancing the understanding of multi-organ interactions through innovative bioreactor designs.
Latest Patents
Soenksen's latest patents include a modular organ microphysiological system with integrated pumping, leveling, and sensing. This fluidic multiwell bioreactor serves as a microphysiological platform for in vitro investigation of multi-organ crosstalk for extended periods, lasting weeks and months. The platform features several improvements over existing bioreactors, such as on-board pumping for pneumatically driven fluid flow, a redesigned spillway for self-leveling, and a non-contact built-in fluid level sensing device. It allows for precise control over fluid flow profiles and partitioning, as well as easy reconfigurations like daisy chaining and multilayer stacking. This innovative platform supports the culture of multiple organs in an interactive microphysiological system, making it suitable for a wide range of biomedical applications, including systemic toxicity studies and physiology-based pharmacokinetic and pharmacodynamic predictions.
Career Highlights
Luis Soenksen is affiliated with the Massachusetts Institute of Technology, where he continues to push the boundaries of research in biomedical applications. His work has garnered attention for its potential to revolutionize how researchers study organ interactions and drug responses.
Collaborations
Soenksen collaborates with notable colleagues, including Linda G. Griffith and David L. Trumper. Their combined expertise enhances the research and development of innovative solutions in the field.
Conclusion
Luis Soenksen's contributions to microphysiological systems exemplify the intersection of innovation and biomedical research. His patents reflect a commitment to advancing our understanding of complex biological interactions, paving the way for future breakthroughs in healthcare.